Ketamine Therapy Seattle
The most complete directory of ketamine therapy providers in Seattle
- Compare all the clinics in Seattle that provide ketamine therapy
- Find the right ketamine therapy provider in your area
- Schedule a free consultation
Primary physician: Dr. Jason Chang
Operating since: 2022
Number of clinics: 1
Treatment areas: Treatment-resistant depression, anxiety, bipolar, PTSD, OCD, migraines, and suicidal ideation
Ketamine therapy services: Clinic specializing in ketamine therapy via microdosing, intravenous treatment, Spravato, and intranasal ketamine
Cost: IV ketamine: $3,000 for 6 sessions and $450 for additional sessions. Microdosing: $125/month
Patient feedback:
The reviews for AVYIA are highly positive, highlighting the positive and transformative experiences of clients undergoing treatment with Dr. Chang. Many describe the ketamine therapy as life-changing, with noticeable improvements in mood, anxiety, depression, and overall well-being. Dr. Chang is praised for his caring, professional, and accessible approach, making patients feel supported and understood throughout their treatment journey. The practice is frequently recommended for its knowledgeable staff, clear communication, and effective treatments that have significantly enhanced clients’ quality of life.
There are many factors that influence the cost of ketamine infusions. In Seattle the average cost of a single infusion for a mental health condition is $400. This is $25 less than the national average of $425.[2]
One explanation for the $25 difference is that the cost of living in Seattle is 14% than the national average.
Ketamine, a medication originally approved by the FDA as an anesthetic, is increasingly being used off-label to treat various mental health conditions, including depression, anxiety, post-traumatic stress disorder (PTSD), and substance use disorders.
A 2023 KFF analysis of the US Census Bureau’s Household Pulse Survey found that 32.6% of the adults in Washington reported symptoms of anxiety and/or depressive disorder in February of 2023. This is slightly more than the 32.3% of adults who reported similar symptoms nationwide.
[1] 2020 US Census
[2] May 2024 Meeko clinic directory sampling
